Considering the distinct features of vanin-1 compared with those of other biomarkers, the combined use of vanin-1 with KIM-1 or NGAL will be more useful for the diagnosis of AKI and prediction of damaged renal sites. The gene discussed is LCN2; the disease is acute kidney injury.